封面
市场调查报告书
商品编码
1767687

眼部保健品市场:依成分类型、适应症类型、剂型类型、通路及地区划分

Eye Health Supplements Market, By Ingredients Type, By Indication Type, By Dosage Type, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 223 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年眼部保健补充剂市场规模估计为 32.571 亿美元,预计到 2032 年将达到 54.745 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 7.7%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 32.571亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 7.70% 2032年价值预测 54.745亿美元

由于萤幕使用时间和数位设备接触时间的增加,眼部健康问题日益受到关注。常见的眼睛问题包括眼睛疲劳、眼干、眼红、眼睛刺激和流泪。此外,常见的眼部疾病包括老龄化黄斑部病变(AMD)、白内障和青光眼。老龄化黄斑部病变是一种会随着时间的推移而恶化的眼部疾病。虽然这种疾病不会导致失明,但会导致严重的视力问题。眼部疾病的主要症状包括视力模糊和色觉障碍。

白内障是指水晶体变得混浊,导致视力模糊、混浊和变色。白内障的主要症状包括视力模糊、复视和夜间视力下降。青光眼是一种损害视神经的眼部疾病。青光眼与眼压升高有关。眼压升高会损害视神经。如果损害严重,青光眼会导致永久性视力丧失。青光眼的主要症状包括眼睛充血、眼痛和灯光周围的晕光感。医生会开一些含有叶黄素、玉米黄质、 Omega-3脂肪酸、维生素 A、β-胡萝卜素和越橘萃取物等成分的药物,用于治疗白内障、青光眼等眼部疾病。

市场动态

预计监管机构核准新产品将在预测期内推动全球眼部保健补充剂市场的成长。例如,2023年3月7日,专注于开发眼部护理产品的生物製药公司NovaBay Pharmaceuticals, Inc.推出了Avenova眼部健康支援产品,这是一款富含抗氧化剂的新型口服补充剂,可缓解眼部干涩并促进整体眼部健康。

本研究的主要特点

  • 本报告对全球眼部保健补充剂市场进行了详细分析,以 2024 年为基准年,预测了 2025 年至 2032 年期间的市场规模。
  • 它揭示了不同领域的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司概况、业绩、产品系列、地理位置、分销策略、关键发展和策略等参数,介绍了全球眼部保健补充剂市场的主要企业概况。
  • 本报告的见解将使企业负责人和经营团队能够就未来的产品发布、政府倡议、技术升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该行业的各个相关人员,例如全球眼部保健补充剂市场的投资者、产品製造商、经销商、供应商、研究公司、咨询公司、新进业者和金融分析师。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 市场机会
  • 影响分析
  • 最新产品发布
  • 流行病学
  • 合併、收购和合作
  • 监管情景
  • 主要进展
  • PEST分析

4. 2020-2032 年全球眼部保健补充品市场(依成分类型)

  • 叶黄素和玉米黄质
  • Omega-3脂肪酸
  • 维生素A
  • β-胡萝卜素
  • 越橘萃取物
  • 其他的

5. 2020 年至 2032 年全球眼部保健补充品市场(依适应症类型划分)

  • 老龄化黄斑部病变(AMD)
  • 白内障
  • 干眼症
  • 青光眼
  • 其他的

6. 全球眼部保健补充品市场(依配方类型),2020-2032 年

  • 锭剂
  • 胶囊
  • 软胶囊
  • 其他的

7. 全球眼部保健补充品市场(依通路划分),2020-2032 年

  • 医院药房
  • 零售药局
  • 网路药局

8. 2032 年全球眼部保健补充品市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第九章 竞争态势

  • Pfizer Inc
  • Bausch Health Companies Inc
  • Alcon
  • Alliance Pharma PLC
  • Allied Biotech Corporation
  • BASF SE
  • Amway India Enterprises Pvt. Ltd
  • Butterflies Healthcare Ltd
  • Herbalife International, Inc
  • Nordic Naturals
  • Vitabiotics Ltd
  • Akorn Operating Company LLC

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI3791

Eye Health Supplements Market is estimated to be valued at USD 3,257.1 Mn in 2025 and is expected to reach USD 5,474.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,257.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.70% 2032 Value Projection: USD 5,474.5 Mn

Eye health is a growing concern owing to increased screen time and digital exposure. Common eye problems include eye strain, dry and red eyes, eye irritation, and watery eyes. Moreover, common eye diseases include Age-related Macular Degeneration (AMD), cataract, and glaucoma. Age-related macular degeneration is an eye disease that gets severe over time. The disease does not cause blindness but can cause severe vision-related problems. Some of the major symptoms of eye problems are less clear vision and worse colour perception.

Cataract occurs when the natural lens of eyes become cloudy. Proteins present in the eyes break down and this causes things to look blurry, hazy, or less colourful. Some of the major symptoms of cataract are blurry vision, seeing double objects, and having trouble seeing at night. Glaucoma is an eye disease that damages eye's optic nerve. Glaucoma is related to the build up of pressure inside the eyes. The increased pressure can cause damage to the optic nerve. If the damage is severe glaucoma can cause permanent vision loss. Some of the major symptoms of glaucoma are redness in eyes, eye pain, and seeing halos around light. Doctors prescribe medicines for eye related diseases, such as cataract, glaucoma, and others, which include ingredients such as lutein and zeaxanthin, omega-3 fatty acids, vitamin A, beta-carotene, and bilberry extracts.

Market Dynamics

Approval of new products by regulatory bodies is expected to propel the global eye health supplement market growth during the forecast period. For instance, on March 7, 2023, NovaBay Pharmaceuticals, Inc, a biopharmaceutical company that develops products for the eye care market, launched Avenova Eye Health Support, a new antioxidant-rich oral supplement to comfort dry eyes and promote the overall eye health.

Key features of the study:

  • This report provides an in-depth analysis of the global eye health supplements market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%) for the forecast period: 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global eye health supplement market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • The key players covered as a part of this study include: Pfizer, Inc., Bausch Health Companies Inc., Alcon Laboratories, Inc., Alliance Pharma PLC, Allied Biotech Corporation, BASF SE, Amway Corp., Butterflies Healthcare Ltd, Herballife Nutrition Ltd., SUSS Technology Corp., Eyescience Labs, Nordic Naturals, Vitabiotics Ltd., and Akorn Incorporated
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global eye health supplement market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for the global eye health supplements market, research and consulting firms, new entrants, and financial analysts

Market Segmentation:

  • Global Eye Health Supplements Market, By Ingredients Type:
    • Lutein And Zexanthin
    • Omega- 3 Fatty Acids
    • Vitamin A
    • Beta Carotene
    • Bilberry Extracts
    • Others
  • Global Eye Health Supplements Market, By Indication Type:
    • Age-related Macular Degeneration (AMD)
    • Cataract
    • Dry Eye Syndrome
    • Glaucoma
    • Others
  • Global Eye Health Supplements Market, By Dosage Type:
    • Tablets
    • Capsules
    • Soft Gels
    • Others
  • Global Eye Health Supplements Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Eye Health Supplements Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc
    • Bausch Health Companies Inc
    • Alcon
    • Alliance Pharma PLC
    • Allied Biotech Corporation
    • BASF SE
    • Amway India Enterprises Pvt. Ltd
    • Butterflies Healthcare Ltd
    • Herbalife International, Inc
    • Nordic Naturals
    • Vitabiotics Ltd
    • Akorn Operating Company LLC.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Ingredients Type
    • Market Snapshot, By Indication Type
    • Market Snapshot, By Dosage Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Eye Health Supplements Market, By Ingredients Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Lutein and Zeaxanthin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Omega-3 Fatty Acids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Vitamin A
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Beta - Carotene
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Bilberry Extracts
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

5. Global Eye Health Supplements Market, By Indication Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Age-related Macular Degeneration (AMD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Cataract
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Dry Eye Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Glaucoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Eye Health Supplements Market, By Dosage Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Soft Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Eye Health Supplements Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

8. Global Eye Health Supplements Market, By Region, 2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bausch Health Companies Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alcon
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alliance Pharma PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Allied Biotech Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amway India Enterprises Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Butterflies Healthcare Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Herbalife International, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nordic Naturals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vitabiotics Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Akorn Operating Company LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us